Oxy 3-in-1 Acne Cleansing Pads

Description

The product is identified by SPL code 34089-3 and is formulated as a topical acne treatment. It contains active ingredients specifically designed to treat and prevent acne. The formulation consists of a combination of cleansing pads, which facilitate easy application and enhance user convenience. Inactive ingredients include water, glycerin, and other components that contribute to the product's overall effectiveness and stability.

Uses and Indications

This drug is indicated for the treatment of acne. It effectively clears acne pimples and facilitates skin healing. The formulation penetrates pores to control the formation of blackheads and whiteheads, while also helping to prevent the emergence of new acne pimples.

Dosage and Administration

Healthcare professionals are advised to initiate treatment by thoroughly cleaning the affected skin area with a wipe. A thin layer of the medication should be applied to the entire affected area one to three times daily, depending on the patient's needs and the physician's recommendations.

It is recommended to start with one application per day to minimize the risk of excessive drying of the skin. Based on the patient's response, the frequency of application may be gradually increased to two or three times daily. In cases where bothersome dryness or peeling occurs, the application frequency should be reduced to once daily or every other day to alleviate these symptoms.

Contraindications

The product is contraindicated in patients who may leave the pad on the skin for extended periods. Prolonged contact with the skin may lead to adverse effects. No other contraindications have been identified.

Warnings and Precautions

For external use only. It is imperative to avoid contact with the eyes, lips, and mouth. In the event of contact, the affected area should be flushed thoroughly with water to mitigate any potential irritation.

Caution is advised when using this product in conjunction with other topical acne medications, as the likelihood of skin irritation and dryness may increase. To minimize the risk of adverse effects, it is recommended to use only one topical acne medication at a time. Additionally, the pad should not be left on the skin for extended periods.

Healthcare professionals should advise patients who are pregnant or breastfeeding to consult with a qualified health professional prior to use to ensure safety for both the mother and child.

In case of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay to address potential toxicity.

Side Effects

Patients using this product should be aware that it is for external use only. The use of this product in conjunction with other topical acne medications may increase the likelihood of skin irritation and dryness. In the event that irritation occurs, it is advised that only one topical acne medication be used at a time to minimize adverse reactions.

For pregnant or breastfeeding individuals, it is recommended to consult a health professional prior to use to ensure safety for both the patient and the child.

Additionally, this product should be kept out of reach of children. In cases where the product is swallowed, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

Drug Interactions

Concurrent use of topical acne medications may increase the risk of skin irritation and dryness. It is advisable to limit the use of topical acne treatments to one at a time to minimize the potential for adverse effects. If irritation occurs, the patient should discontinue the use of additional topical acne medications and consult a healthcare professional for further guidance.

Packaging & NDC

Below are the non-prescription pack sizes of Oxy 3-in-1 Acne Cleansing Pads (salicylic acid 2%). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is recommended.

For topical application, it is advised to initiate treatment with one application daily to minimize the risk of excessive skin drying. Dosage may be gradually increased to 2 or 3 times daily as needed or directed by a healthcare professional. Should patients experience bothersome dryness or peeling, the frequency of application should be reduced to once daily or every other day.

Geriatric Use

There is no specific information regarding the use of OXY 3-IN-1 Acne Cleansing Pads in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when recommending this product to elderly patients, as the absence of data necessitates careful consideration of individual patient factors and potential sensitivities. Monitoring for any adverse reactions or skin irritations is advisable when this product is used in the geriatric population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits, as well as any available data regarding fetal outcomes and lactation. Healthcare providers can offer guidance tailored to individual circumstances, ensuring the safety of both the patient and the developing fetus or nursing infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. It is imperative that healthcare providers remain vigilant and prepared to address any complications that may arise from an overdosage scenario.

Nonclinical Toxicology

Pregnant or breastfeeding individuals are advised to consult a health professional prior to use.

Skin irritation and dryness may be exacerbated when used concurrently with other topical acne medications. In cases of irritation, it is recommended to limit the use to one topical acne treatment at a time. Should bothersome dryness or peeling occur, it is advisable to reduce the frequency of application to once daily or every other day.

No specific information regarding nonclinical toxicology or animal pharmacology and toxicology is available in the insert.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to emphasize the need to keep the product away from the eyes, lips, and mouth. In the event of contact with these areas, patients should be instructed to flush thoroughly with water.

Providers should also inform patients that using this product in conjunction with other topical acne medications may increase the likelihood of skin irritation and dryness. If patients experience irritation, they should be counseled to limit their use to one topical acne medication at a time to minimize adverse effects.

Additionally, patients should be cautioned not to leave the pad on the skin for extended periods, as this may lead to unwanted reactions. Clear communication of these points will help ensure safe and effective use of the product.

Storage and Handling

The product is supplied in a tightly sealed container to ensure integrity and stability. It is essential to protect the product from freezing and to keep it away from flame, fire, and heat sources. Storage conditions should be maintained at temperatures not exceeding 100 °F (38 °C) to preserve the quality of the product. Additionally, it is important to avoid flushing the product. Proper handling and storage practices are crucial for maintaining the efficacy and safety of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Oxy 3-in-1 Acne Cleansing Pads, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)